Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders
Therapeutic Development in the Absence of Predictive Animal Models of Nervous System Disorders - Engineering, and Medicine National Academies of Sciences,Health and Medicine Division,Board on Health Sciences Policy,Forum on Neuroscience and Nervous System Disorders Nedostupné

Kniha ( měkká vazba )

    • Produkt je nedostupný.
E-shopové listy

Při zaslání zboží balíčkem

K nákupu nad 99 Kč dárek zdarma v hodnotě 19 Kč

E-shopové listy

Druhá půlka Augusty Hopeové

Při zaslání zboží balíčkem

K nákupu nad 999 Kč dárek zdarma v hodnotě 399 Kč

Druhá půlka Augusty Hopeové

Compared with other disease areas, central nervous system (CNS) disorders have had the highest failure rate for new compounds in advanced clinical trials. Most CNS drugs fail because of efficacy, and the core issue underlying these problems is a poor understanding of disease biology. Concern about the poor productivity in neuroscience drug… Přejít na celý popis

Popis

Compared with other disease areas, central nervous system (CNS) disorders have had the highest failure rate for new compounds in advanced clinical trials. Most CNS drugs fail because of efficacy, and the core issue underlying these problems is a poor understanding of disease biology. Concern about the poor productivity in neuroscience drug development has gained intensity over the past decade, amplified by a retraction in investment from the pharmaceutical industry. This retreat by industry has been fueled by the high failure rate of compounds in advanced clinical trials for nervous system disorders. In response to the de-emphasis of CNS disorders in therapeutic development relative to other disease areas such as cancer, metabolism, and autoimmunity, the National Academies of Sciences, Engineering, and Medicine initiated a series of workshops in 2012 to address the challenges that have slowed drug development for nervous system disorders. Motivated by the notion that advances in genetics and other new technologies are beginning to bring forth new molecular targets and identify new biomarkers, the Academies hosted the third workshop in this series in September 2016. Participants discussed opportunities to accelerate early stages of drug development for nervous system disorders in the absence of animal models that reflect disease and predict efficacy. This publication summarizes the presentations and discussions from the workshop.

Sdílet

Nakladatel
National Academies Press
Rozměr
152 x 229 x 25
jazyk
angličtina
Vazba
měkká vazba
Hmotnost
164 g
isbn
978-0-309-45513-8
Počet stran
94
datum vydání
24.05.2017
ean
9780309455138

Hodnocení a recenze čtenářů Nápověda

0.0 z 5 0 hodnocení čtenářů

5 hvězdiček 4 hvězdičky 3 hvězdičky 2 hvězdičky 1 hvezdička

Přidejte své hodnocení knihy

Další knihy autora

Další knihy autora

Všechny knihy autora

Všechny knihy autora

Vývoj ceny

Vývoj ceny Nápověda

Získejte přehled o vývoji ceny za posledních 60 dní.

Maloobchodní cena Minimální prodejní cena: 0 Kč Nápověda